The show that helps you maximize your wealth by turning complex financial situations into actionable advice. On Your Money. Your Mission., we answer the questions you’ve been asking about -- financial planning, investing, retirement and everything in between. Whether you’re navigating the complexities of the market or looking for the best ways to save or spend your money, tune in to hear from experienced financial advisors with JFG. Walk away from each episode with savvy tips and financial t ...
…
continue reading
Content provided by The European VC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The European VC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
VC | E525 | Jean Schmitt & Rob Blackie on the State of RNA in Europe & the TechBio Opportunity
MP3•Episode home
Manage episode 495307439 series 2968392
Content provided by The European VC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The European VC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this week's podcast, Andreas Munk Holm is joined by Jean Schmitt at Jolt Capital and Rob Blackie at Crampton Blackie to explore one of the most consequential deep tech opportunities Europe faces: RNA. With roots in foundational biology and applications from cancer therapy to precision agriculture, RNA is both a symbol and a stress test of Europe’s capacity to scale science into sovereignty.
The conversation is based on their Landmark 2025 Report on the State of RNA in Europe, a data-rich, in-depth analysis of patents, funding flows, regulatory bottlenecks, and startup activity across the continent.
Here’s what’s covered:
…
continue reading
The conversation is based on their Landmark 2025 Report on the State of RNA in Europe, a data-rich, in-depth analysis of patents, funding flows, regulatory bottlenecks, and startup activity across the continent.
Here’s what’s covered:
- 03:05 The State of RNA in Europe
- 05:59 Challenges in Commercialization and Investment
- 09:09 The Landscape of RNA Companies in Europe
- 15:02 Regulatory Challenges in RNA Development
- 17:58 The Future of RNA in Europe
- 26:54 Navigating Regulatory Challenges in Biocontrol Products
- 30:46 The Impact of European Policies on Innovation
- 32:41 Learning from Global Regulatory Practices
- 40:34 The Exodus of Talent and Innovation from Europe
- 45:59 Funding Challenges for RNA Companies in Europe
533 episodes
MP3•Episode home
Manage episode 495307439 series 2968392
Content provided by The European VC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The European VC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this week's podcast, Andreas Munk Holm is joined by Jean Schmitt at Jolt Capital and Rob Blackie at Crampton Blackie to explore one of the most consequential deep tech opportunities Europe faces: RNA. With roots in foundational biology and applications from cancer therapy to precision agriculture, RNA is both a symbol and a stress test of Europe’s capacity to scale science into sovereignty.
The conversation is based on their Landmark 2025 Report on the State of RNA in Europe, a data-rich, in-depth analysis of patents, funding flows, regulatory bottlenecks, and startup activity across the continent.
Here’s what’s covered:
…
continue reading
The conversation is based on their Landmark 2025 Report on the State of RNA in Europe, a data-rich, in-depth analysis of patents, funding flows, regulatory bottlenecks, and startup activity across the continent.
Here’s what’s covered:
- 03:05 The State of RNA in Europe
- 05:59 Challenges in Commercialization and Investment
- 09:09 The Landscape of RNA Companies in Europe
- 15:02 Regulatory Challenges in RNA Development
- 17:58 The Future of RNA in Europe
- 26:54 Navigating Regulatory Challenges in Biocontrol Products
- 30:46 The Impact of European Policies on Innovation
- 32:41 Learning from Global Regulatory Practices
- 40:34 The Exodus of Talent and Innovation from Europe
- 45:59 Funding Challenges for RNA Companies in Europe
533 episodes
Alle episoder
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.